Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. billion, servicing nearly 340,000 active patients.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Cannabis Law Report

AUGUST 22, 2021

Silo Pharma’s notice of allowance paves the way toward clinical trials for its psychedelics delivery platform using homing peptides. According to Global Industry Analysts , the global CNS therapeutics market could reach more than $132 billion by 2024. Silo Pharma Inc. Looking to the Future. Silo Pharma Inc.

Clinical Trials 105

Clinical Trials Research and Development Safety Treatment 105

Cannabis Law Report

JUNE 23, 2021

The company’s target is 20 clinics by the end of 2024. “The NEO listing will enable us to accelerate the execution of our drug discovery, therapy development, advanced analytics, and open clinic rollout programs.”. Celia Morgan). David Nutt), starts in Q4 2021.

Clinical Trials 110

Clinical Trials Therapy Research and Development Treatment 110

Cannabis Law Report

MAY 31, 2022

The only psychedelic drug that is approved (outside of clinical trials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine. Food and Drug Administration (FDA) approved esketamine (a component of Ketamine and sold under the brand name Spravato) for treatment-resistant depression.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

Cannabis Law Report

DECEMBER 2, 2021

Practicum training is a major focus of the proposed training curriculum, and as the program matures, students will observe and facilitate psilocybin treatment sessions under the supervision of a Practicum Site Supervisor. Group Psilocybin Facilitation (8 Hours).

Law 52

Law Programs Therapy Education 52

Cannabis Law Report

AUGUST 30, 2019

billion by 2024. Professional athletes are increasingly turning to cannabis as an alternative form of pain management treatment and as a business opportunity in retirement. The joint venture will seek to capitalize on the southeast Asian market, which is expected to be worth $5.8 Medical/Health.

Banking 45

Banking Research and Development Legislation Programs 45

Veriheal

JULY 18, 2023

Recognizing that the efficacy of treatment relies not only on the therapeutic substances themselves but also on the skill and knowledge of the individuals administering them, this bill explicitly supports the training of practitioners. Nancy Mace (R-SC), Matt Gaetz (R-FL), and Jack Bergman (R-MI) representing the Republican party.

Treatment 98

Treatment Clinical Trials Research and Development Legislation 98